Form D — Goldenrod Therapeutics, Inc.
0002127885-26-000001 · filed Jun 3, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $6,510,000
- Total sold
- $3,245,355
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Goldenrod Therapeutics, Inc.
- CIK
- 2127885
- Entity
- Corporation
- Jurisdiction
- TEXAS
- Year incorporated
- 2023
- Address
- 3900 ESSEX LANE, SUITE 575
HOUSTON, TX 77027 - Phone
- 713-966-5844
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Leo Linbeck III · DirectorHouston, TX Find on LinkedIn ↗
-
Atul Varadhachary · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Thomas Brenninkmeijer · DirectorHouston, TX Find on LinkedIn ↗
-
Dev Chatterjee · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Leo Linbeck IV · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Mark Worscheh · Executive OfficerHouston, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗